Jacob Atsmon

Oral Octreotide Absorption in Human Subjects: Comparable Pharmacokinetics to Parenteral Octreotide and Effective Growth Hormone Suppression

Shmuel Tuvia, Jacob Atsmon, Sam L. Teichman et al. · The Journal of Clinical Endocrinology & Metabolism · 2012 · 152 citations · Full text

Safety and Immunogenicity of Multimeric-001—a Novel Universal Influenza Vaccine

Jacob Atsmon, Efrat Kate-Ilovitz, Dimitry Shaikevich et al. · Journal of Clinical Immunology · 2012 · 144 citations · Full text

Vaccination, Immunology, Influenza Vaccine +3

Safety and immunogenicity of a synthetic carbohydrate conjugate vaccine against Shigella flexneri 2a in healthy adult volunteers: a phase 1, dose-escalating, single-blind, randomised, placebo-controlled study

Dani Cohen, Jacob Atsmon, Cécile Artaud et al. · The Lancet Infectious Diseases · 2020 · 92 citations

Vaccination, Healthy Adult Volunteers, Cross-protection +10

Formation of thiol conjugates of 9-deoxy-.DELTA.9,.DELTA.12(E)-prostaglandin D2 and .DELTA.12(E)-prostaglandin D2

Jacob Atsmon, Brian J. Sweetman, Steven W. Baertschi et al. · Biochemistry · 1990 · 90 citations

Conjugation of 9-deoxy-delta 9,delta 12(E)-prostaglandin D2 with intracellular glutathione and enhancement of its antiproliferative activity by glutathione depletion.

Jacob Atsmon, Michael L. Freeman, Michael Meredith et al. · PubMed · 1990 · 90 citations

Glycobiology, Glucocorticoid, Redox Biology +19